WHO's emergency use authorization to Covaxin delayed over technical queries: Report
Image Credit: shortpedia
WHO has further delayed the emergency use authorisation (EUA) for Bharat Biotech's Covaxin--the COVID-19 vaccine developed in India--as the global body has sent more technical queries to its manufacturer, NDTV reported quoting sources. On Friday, the Union Health Ministry had hinted that WHO's emergency use authorization to Covaxin is expected soon.